A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete… Read More

For a long time, the molecular biomarkers EGFR/ALK have been used to test for lung cancer, one of the most common diseases diagnosed globally. Thanks to advancements and early identification… Read More

Kaala Paani takes place in 2027 and is centered around a fictional epidemic called LHF-27 caused by the contamination of a lake in the Andaman and Nicobar Islands. Even though the warning si… Read More

In recent years, PROteolysis TArgeting Chimeras (PROTAC), which utilizes the cell’s own degradation mechanisms to eliminate specific disease-related proteins, has emerged as one of the… Read More

Genprex (NASDAQ: GNPX) is at the forefront of pioneering cancer treatments, and it’s making waves with remarkable advancements in lung cancer therapy. The company will be sharing compe… Read More

Oncology Precision Medicine Market, Size, Global Forecast 2022-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis. The report also includes an a… Read More

Over the past decade, significant strides have been made in the realm of peptide drug development courtesy of ground-breaking advancements in produc… Read More

Home | Blogs New Hope Emerges for Triple Negative Breast Cancer Patients… Read More

[Sept. 18, 2023: Vinod P. Balachandran, Memorial Sloan Kettering Cancer Center] The key to these vaccines appears to be proteins in the pancreatic tumors, called neoantigens, which alert th… Read More

Introduction        Intrahepatic cholangiocarcinoma (ICC), a rare and aggressive form of… Read More

New research in colorectal cancers directed by investigators at the Johns Hopkins Kimmel Cancer Center suggests that expression of transcription factors — proteins that help turn spe… Read More

On August 23, 2023, BOXER CAPITAL, LLC, a San Diego-based investment firm, reduced its stake in ITeos Therapeutics Inc ( ITOS, Financial). The firm sold 350,000 shares at a price of $16.26 p… Read More

Introduction In recent years, the landscape of cancer treatment has witnessed a revolutionary breakthrough with th… Read More